Malaysia Blood Plasma Market – Industry Trends and Forecast to 2026

  • Healthcare
  • Published Report
  • Oct 2019
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 11
  • No of Figures: 29

Malaysia Blood Plasma Market By Type (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Other Plasma Products), Application (Neurology, Immunology, Haematology, Critical Care, Pulmonology, Haemato-Oncology, Rheumatology, Other Applications), End User (Hospital, Clinics, Clinical Research Laboratories, Academic Institutes), Country (Singapore, Malaysia and Thailand). – Industry Trends and Forecast to 2026

Blood plasma is used in the treatment of blood disorders and in medical products which consists 55% of total blood volume. The products of blood plasma are plasma derivatives, which are used in the transfusion of blood and are helpful in the treatment of blood disorder. There is an increase in the prevalence of blood plasma disorders which is increasing the demand for blood.

Malaysia blood plasma market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.

Segmentation: Malaysia Blood Plasma Market

Malaysia blood plasma market is segmented into three notable segments which are based on the basis of type, application and end user

  • On the basis of type, the market is segmented into immunoglobulin, coagulation factor concentrates, albumin, protease inhibitors and other plasma products
  • On the basis of application, the market is segmented into neurology, haematology, critical care, pulmonology, hamate-oncology, rheumatology, immunology and other applications
  • On the basis of end user, the market is segmented into hospitals, clinics, clinical research laboratories and academic institutes  

Competitive Analysis: Malaysia Blood Plasma Market

Some of the major players operating in Malaysia blood plasma market are CSL Limited, Grifols, S.A., Takeda Pharmaceutical Company Limited and Octapharma AG among others.

Research Methodology: Malaysia Blood Plasma Market

Primary Rependants:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors, Doctor, neurosurgeons, spine surgeons, ophthalmologist, Nurses, Medical Practitioners & Healthcare Professionals

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and National Sales Managers


SKU-

TABLE 1 POPULATION STATISTICS WITH BLOOD DISORDER

TABLE 2 MALAYSIA BLOOD PLASMA MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 3 MALAYSIA IMMUNOGLOBULIN IN BLOOD PLASMA MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 4 MALAYSIA COAGULATION FACTOR CONCENTRATES IN BLOOD PLASMA MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 5 MALAYSIA BLOOD PLASMA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 6 MALAYSIA BLOOD PLASMA MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 7 MALAYSIA BLOOD PLASMA MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 8 MALAYSIA IMMUNOGLOBULIN IN BLOOD PLASMA MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 9 MALAYSIA COAGULATION FACTOR CONCENTRATES IN BLOOD PLASMA MARKET, BY TYPE, 2017 - 2026 (USD MILLION)

TABLE 10 MALAYSIA BLOOD PLASMA MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)

TABLE 11 MALAYSIA BLOOD PLASMA MARKET, BY END USER, 2017 - 2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE